Yoshinaga Okugawa Selected Research

Infections

9/2022	Anti-inflammatory and nutritional improvement effects of dietary supplementation combined with fish oil in patients with epithelial cancer.
1/2021	Modified intramuscular adipose tissue content as a feasible surrogate marker for malnutrition in gastrointestinal cancer.
3/2015	Immunodeficiency and autoimmune enterocolopathy linked to NFAT5 haploinsufficiency.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yoshinaga Okugawa Research Topics

Disease

76	Neoplasms (Cancer) 04/2024 - 04/2008
64	Colorectal Neoplasms (Colorectal Cancer) 01/2024 - 04/2008
34	Rectal Neoplasms (Rectal Cancer) 12/2023 - 10/2009
31	Neoplasm Metastasis (Metastasis) 01/2023 - 07/2009
21	Stomach Neoplasms (Stomach Cancer) 04/2024 - 03/2010
16	Lymphatic Metastasis 02/2024 - 07/2009
12	Inflammation (Inflammations) 05/2023 - 02/2014
11	Carcinogenesis 05/2023 - 02/2011
10	Colonic Neoplasms (Colon Cancer) 05/2023 - 01/2007
9	Residual Neoplasm 01/2024 - 10/2009
8	Esophageal Neoplasms (Esophageal Cancer) 02/2024 - 11/2011
8	Ulcerative Colitis 08/2023 - 02/2014
6	Disease Progression 01/2024 - 01/2003
5	Gastrointestinal Neoplasms (Gastrointestinal Cancer) 01/2021 - 01/2017
4	Surgical Wound Infection 12/2023 - 01/2020
3	Adenocarcinoma 10/2023 - 07/2021
3	Infections 09/2022 - 03/2015
3	Sarcopenia 01/2021 - 04/2018
3	Adenoma (Adenomas) 12/2018 - 02/2011
2	Fistula 10/2023 - 09/2013
2	Sigmoid Neoplasms 05/2023 - 11/2014
2	Adenocarcinoma of Lung 01/2023 - 12/2014
2	Lung Neoplasms (Lung Cancer) 01/2023 - 01/2020
2	Chronic Obstructive Pulmonary Disease (COPD) 11/2022 - 02/2019
2	Microsatellite Instability 01/2020 - 04/2016
2	Weight Loss (Weight Reduction) 01/2019 - 11/2018
2	Cachexia 11/2018 - 01/2017
2	Colitis 12/2017 - 05/2010
2	Esophageal Squamous Cell Carcinoma 01/2015 - 11/2011
2	Thrombosis (Thrombus) 01/2015 - 08/2011
2	Adenomatous Polyposis Coli (Familial Adenomatous Polyposis) 11/2014 - 02/2011
2	Peritoneal Neoplasms 01/2014 - 04/2013
2	Body Weight (Weight, Body) 12/2008 - 04/2008

Drug/Important Bio-Agent (IBA)

45	Biomarkers (Surrogate Marker)IBA 10/2023 - 04/2008
19	MicroRNAs (MicroRNA)IBA 12/2022 - 03/2014
17	C-Reactive ProteinIBA 04/2024 - 12/2008
15	Proteins (Proteins, Gene)FDA Link 10/2022 - 08/2010
11	RNA (Ribonucleic Acid)IBA 05/2023 - 03/2011
11	Messenger RNA (mRNA)IBA 12/2017 - 08/2010
7	Fluorouracil (Carac)FDA LinkGeneric 04/2016 - 05/2012
6	Small Interfering RNA (siRNA)IBA 10/2020 - 03/2010
5	AlbuminsIBA 04/2024 - 10/2017
5	Indicators and Reagents (Reagents)IBA 01/2021 - 01/2018
5	Serum AlbuminIBA 01/2021 - 04/2008
5	Calcibiotic Root Canal SealerIBA 01/2020 - 03/2015
5	CytokinesIBA 01/2019 - 02/2014
4	imidazoleacetic acid (IMAC)IBA 01/2023 - 04/2018
4	Long Noncoding RNAIBA 10/2020 - 12/2014
4	Tumor Biomarkers (Tumor Markers)IBA 01/2020 - 06/2008
4	EnzymesIBA 12/2018 - 07/2009
4	Green Fluorescent ProteinsIBA 01/2015 - 01/2012
4	Formaldehyde (Formol)FDA Link 10/2014 - 12/2009
4	ParaffinIBA 10/2014 - 12/2009
3	Adenosine (Adenocard)FDA LinkGeneric 05/2023 - 01/2018
3	Inosine FDA Link 05/2023 - 01/2018
3	Immunoglobulin A (IgA)IBA 05/2023 - 11/2018
3	ErbB Receptors (EGF Receptor)IBA 01/2023 - 11/2014
3	Fish OilsIBA 09/2022 - 01/2017
3	Irinotecan (Camptosar)FDA LinkGeneric 04/2019 - 11/2012
3	LigandsIBA 03/2019 - 08/2010
3	GTPase-Activating Proteins (GTPase-Activating Protein)IBA 01/2019 - 01/2015
3	Carcinoembryonic AntigenIBA 10/2017 - 12/2008
3	Red Fluorescent ProteinIBA 11/2012 - 01/2012
3	Hepatocyte Growth Factor (Growth Factor, Hepatocyte)IBA 04/2012 - 10/2009
2	6-methyladenineIBA 02/2023 - 01/2022
2	Tyrosine Kinase InhibitorsIBA 01/2023 - 02/2012
2	mitomycin C-immunoglobulin M antibody conjugateIBA 01/2023 - 01/2021
2	CateninsIBA 10/2022 - 10/2015
2	Interleukin-6 (Interleukin 6)IBA 09/2022 - 01/2019
2	Eicosapentaenoic AcidIBA 09/2022 - 01/2017
2	Monoclonal AntibodiesIBA 06/2022 - 01/2013
2	InterleukinsIBA 01/2019 - 02/2014
2	immune RNA (I-RNA)IBA 01/2019 - 01/2018
2	GlobulinsIBA 01/2018 - 11/2017
2	Transcription Factors (Transcription Factor)IBA 10/2016 - 09/2012
2	Angiopoietin-Like Protein 2IBA 12/2015 - 12/2014
2	Untranslated RNA (Noncoding RNA)IBA 10/2015 - 12/2014
2	CurcuminIBA 05/2015 - 03/2015
2	LipopolysaccharidesIBA 01/2015 - 02/2014
2	Phosphotransferases (Kinase)IBA 01/2014 - 01/2013
2	Proliferating Cell Nuclear Antigen (PCNA)IBA 09/2012 - 11/2010
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 09/2012 - 10/2009
2	AntibodiesIBA 04/2011 - 11/2010
2	ImmunosorbentsIBA 03/2011 - 07/2009
1	Circulating Tumor DNAIBA 01/2024

Therapy/Procedure

28	Chemoradiotherapy 12/2023 - 10/2009
19	Drug Therapy (Chemotherapy) 01/2024 - 11/2010
15	Therapeutics 01/2024 - 10/2009
12	Neoadjuvant Therapy 02/2024 - 04/2012
7	Lasers (Laser) 04/2016 - 08/2011
6	Gastrectomy 04/2024 - 06/2019
5	Esophagectomy 12/2023 - 04/2011
4	Restorative Proctocolectomy 01/2021 - 02/2014
4	Palliative Care (Palliative Therapy) 08/2019 - 01/2017
3	Proctectomy 10/2023 - 01/2019
3	Colectomy 01/2019 - 11/2014
2	Aftercare (After-Treatment) 04/2016 - 01/2003
2	Colonic Pouches (S Pouch) 11/2014 - 02/2014
2	Laparotomy 03/2014 - 10/2007
2	Radiotherapy 05/2013 - 11/2011